SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

12 Aug 2025 Evaluate
The Revenue for the quarter ended  June 2025 of Rs. 2100.90 millions grew by 19.95 % from Rs. 1751.53 millions.A good growth in profit of 31.06% reported to Rs. 176.65  millions over Rs. 134.79 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 317.63 millions from 250.13 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 2100.90 1751.53 19.95 2100.90 1751.53 19.95 7598.78 6309.56 20.43
Other Income 52.39 41.33 26.76 52.39 41.33 26.76 176.46 134.68 31.02
PBIDT 317.63 250.13 26.99 317.63 250.13 26.99 1117.61 915.70 22.05
Interest 10.57 4.92 114.84 10.57 4.92 114.84 43.82 11.03 297.28
PBDT 307.06 245.21 25.22 307.06 245.21 25.22 1073.79 904.67 18.69
Depreciation 74.48 62.10 19.94 74.48 62.10 19.94 279.85 134.44 108.16
PBT 232.58 183.11 27.02 232.58 183.11 27.02 793.94 770.23 3.08
TAX 55.93 48.32 15.75 55.93 48.32 15.75 187.45 188.79 -0.71
Deferred Tax 0.40 2.20 -81.82 0.40 2.20 -81.82 4.72 15.35 -69.25
PAT 176.65 134.79 31.06 176.65 134.79 31.06 606.49 581.44 4.31
Equity 104.80 104.50 0.29 104.80 104.50 0.29 104.80 103.99 0.78
PBIDTM(%) 15.12 14.28 5.87 15.12 14.28 5.87 14.71 14.51 1.34

Windlas Biotech Share Price

800.75 -0.55 (-0.07%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×